Paola León-Mimila1, Joel Vega-Badillo1, Roxana Gutiérrez-Vidal1, Hugo Villamil-Ramírez2, Teresa Villareal-Molina3, Elena Larrieta-Carrasco4, Blanca E López-Contreras2, Luis R Macías Kauffer2, Diana G Maldonado-Pintado5, Nahúm Méndez-Sánchez6, Armando R Tovar7, Rogelio Hernández-Pando8, Rafael Velázquez-Cruz3, Francisco Campos-Pérez5, Carlos A Aguilar-Salinas9, Samuel Canizales-Quinteros10. 1. Programa de Doctorado en Ciencias Bioquímicas, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Instituto Nacional de Medicina Genómica (INMEGEN), México City 14610, Mexico. 2. Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Instituto Nacional de Medicina Genómica (INMEGEN), México City 14610, Mexico. 3. Laboratorio de Enfermedades Cardiovasculares y Óseas, INMEGEN, México City 14610, Mexico. 4. Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" (INCMNSZ), México City 14000, Mexico. 5. Clínica de Obesidad, Hospital Rubén Leñero, México City 11340, Mexico. 6. Unidad de Investigación de Hígado, Fundación Médica Sur, México City 14050, Mexico. 7. Departamento de Fisiología de la Nutrición, INCMNSZ, México City 14000, Mexico. 8. Departamento de Patología Experimental, INCMNSZ, México City 14000, Mexico. 9. Departamento de Endocrinología y Metabolismo, INCMNSZ, México City 14000, Mexico. 10. Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Instituto Nacional de Medicina Genómica (INMEGEN), México City 14610, Mexico. Electronic address: cani@unam.mx.
Abstract
BACKGROUND AND AIMS: Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) near/in PNPLA3, NCAN, LYPLAL1, PPP1R3B, and GCKR genes associated with non-alcoholic fatty liver disease (NAFLD) mainly in individuals of European ancestry. The aim of the study was to test whether these genetic variants and a genetic risk score (GRS) are associated with elevated liver fat content and non-alcoholic steatohepatitis (NASH) in Mexicans with morbid obesity. METHODS: 130 morbidly obese Mexican individuals were genotyped for six SNPs in/near PNPLA3, NCAN, LYPLAL1, PPP1R3B, and GCKR genes. Hepatic fat content [triglyceride (HTG) and total cholesterol (HTC)] was quantified directly in liver biopsies and NASH was diagnosed by histology. A GRS was tested for association with liver fat content and NASH using logistic regression models. In addition, 95 ancestry-informative markers were genotyped to estimate population admixture proportions. RESULTS: After adjusting for age, sex and admixture, PNPLA3, LYPLAL1, GCKR and PPP1R3B polymorphisms were associated with higher HTG content (P < 0.05 for PNPLA3, LYPLAL1, GCKR polymorphisms and P = 0.086 for PPP1R3B). The GRS was significantly associated with higher HTG and HTC content (P = 1.0 × 10(-4) and 0.048, respectively), steatosis stage (P = 0.029), and higher ALT levels (P = 0.002). Subjects with GRS ≥ 6 showed a significantly increased risk of NASH (OR = 2.55, P = 0.045) compared to those with GRS ≤ 5. However, the GRS did not predict NASH status, as AUC of ROC curves was 0.56 (P = 0.219). CONCLUSION: NAFLD associated loci in Europeans and a GRS based on these loci contribute to the accumulation of hepatic lipids and NASH in morbidly obese Mexican individuals.
BACKGROUND AND AIMS: Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) near/in PNPLA3, NCAN, LYPLAL1, PPP1R3B, and GCKR genes associated with non-alcoholic fatty liver disease (NAFLD) mainly in individuals of European ancestry. The aim of the study was to test whether these genetic variants and a genetic risk score (GRS) are associated with elevated liver fat content and non-alcoholic steatohepatitis (NASH) in Mexicans with morbid obesity. METHODS: 130 morbidly obese Mexican individuals were genotyped for six SNPs in/near PNPLA3, NCAN, LYPLAL1, PPP1R3B, and GCKR genes. Hepatic fat content [triglyceride (HTG) and total cholesterol (HTC)] was quantified directly in liver biopsies and NASH was diagnosed by histology. A GRS was tested for association with liver fat content and NASH using logistic regression models. In addition, 95 ancestry-informative markers were genotyped to estimate population admixture proportions. RESULTS: After adjusting for age, sex and admixture, PNPLA3, LYPLAL1, GCKR and PPP1R3B polymorphisms were associated with higher HTG content (P < 0.05 for PNPLA3, LYPLAL1, GCKR polymorphisms and P = 0.086 for PPP1R3B). The GRS was significantly associated with higher HTG and HTC content (P = 1.0 × 10(-4) and 0.048, respectively), steatosis stage (P = 0.029), and higher ALT levels (P = 0.002). Subjects with GRS ≥ 6 showed a significantly increased risk of NASH (OR = 2.55, P = 0.045) compared to those with GRS ≤ 5. However, the GRS did not predict NASH status, as AUC of ROC curves was 0.56 (P = 0.219). CONCLUSION: NAFLD associated loci in Europeans and a GRS based on these loci contribute to the accumulation of hepatic lipids and NASH in morbidly obese Mexican individuals.
Authors: Elena Larrieta-Carrasco; Yvonne N Flores; Luis R Macías-Kauffer; Paula Ramírez-Palacios; Manuel Quiterio; Eric G Ramírez-Salazar; Paola León-Mimila; Berenice Rivera-Paredez; Guillermo Cabrera-Álvarez; Samuel Canizales-Quinteros; Zuo-Feng Zhang; Tania V López-Pérez; Jorge Salmerón; Rafael Velázquez-Cruz Journal: Exp Mol Pathol Date: 2018-01-04 Impact factor: 3.362
Authors: Anna Viitasalo; Aino-Maija Eloranta; Mustafa Atalay; Stefano Romeo; Jussi Pihlajamäki; Timo A Lakka Journal: Pediatr Res Date: 2016-07-13 Impact factor: 3.756
Authors: Yvonne N Flores; Rafael Velázquez-Cruz; Paula Ramírez; Manuel Bañuelos; Zuo-Feng Zhang; Hal F Yee; Shen-Chih Chang; Samuel Canizales-Quinteros; Manuel Quiterio; Guillermo Cabrera-Alvarez; Nelly Patiño; Jorge Salmerón Journal: Mol Biol Rep Date: 2016-10-17 Impact factor: 2.316
Authors: Georg Semmler; Lorenz Balcar; Hannes Oberkofler; Stephan Zandanell; Michael Strasser; David Niederseer; Alexandra Feldman; Felix Stickel; Pavel Strnad; Christian Datz; Bernhard Paulweber; Elmar Aigner Journal: J Pers Med Date: 2021-03-01
Authors: Paola León-Mimila; Hugo Villamil-Ramírez; Luis R Macías-Kauffer; Leonor Jacobo-Albavera; Blanca E López-Contreras; Rosalinda Posadas-Sánchez; Carlos Posadas-Romero; Sandra Romero-Hidalgo; Sofía Morán-Ramos; Mayra Domínguez-Pérez; Marisol Olivares-Arevalo; Priscilla López-Montoya; Roberto Nieto-Guerra; Víctor Acuña-Alonzo; Gastón Macín-Pérez; Rodrigo Barquera-Lozano; Blanca E Del-Río-Navarro; Israel González-González; Francisco Campos-Pérez; Francisco Gómez-Pérez; Victor J Valdés; Alicia Sampieri; Juan G Reyes-García; Miriam Del C Carrasco-Portugal; Francisco J Flores-Murrieta; Carlos A Aguilar-Salinas; Gilberto Vargas-Alarcón; Diana Shih; Peter J Meikle; Anna C Calkin; Brian G Drew; Luis Vaca; Aldons J Lusis; Adriana Huertas-Vazquez; Teresa Villarreal-Molina; Samuel Canizales-Quinteros Journal: Arterioscler Thromb Vasc Biol Date: 2021-07-08 Impact factor: 10.514
Authors: P León-Mimila; H Villamil-Ramírez; X S Li; D M Shih; S T Hui; E Ocampo-Medina; B López-Contreras; S Morán-Ramos; M Olivares-Arevalo; P Grandini-Rosales; L Macías-Kauffer; I González-González; R Hernández-Pando; F Gómez-Pérez; F Campos-Pérez; C Aguilar-Salinas; E Larrieta-Carrasco; T Villarreal-Molina; Z Wang; A J Lusis; S L Hazen; A Huertas-Vazquez; S Canizales-Quinteros Journal: Diabetes Metab Date: 2020-08-10 Impact factor: 6.041